New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - mesalazine 800mg - enteric coated tablet - 800 mg - active: mesalazine 800mg excipient: dibutyl phthalate iron oxide red iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer povidone purified talc   sodium starch glycolate

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - mesalazine 16.67%{relative} - suppository - 16.67% w/w - active: mesalazine 16.67%{relative} excipient: hard fat

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - peppermint oil 187mg;   - modified release capsule - 187 mg/dose - active: peppermint oil 187mg   excipient: arachis oil colloidal silicon dioxide gelatin glyceryl monostearate indigo carmine macrogol 4000 methacrylic acid copolymer purified talc titanium dioxide triethyl citrate water white beeswax

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - budesonide - modified-release capsule - 3mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

equity pharmaceutical (pty) ltd - tablet - see ingredients - each tablet contains mesalazine 400,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

equity pharmaceutical (pty) ltd - suppository - see ingredients - each suppository contains mesalazine 500 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

equity pharmaceutical (pty) ltd - tablet - see ingredients - each tablet contains mesalazine 800,0 mg